In a world driven by precision medicine, genetic testing has become the backbone of cutting-edge healthcare. Among the leading technologies in this domain, the Whole Exome Sequencing Market is witnessing a seismic surge. From rare disease diagnostics to personalized oncology, whole exome sequencing (WES) is no longer just a lab innovation—it's a clinical revolution. The Science...